-
2024-518225-15-00
4
Myelofibrosis
-
2024-518251-31-00
5
patients hospitalized for a septic shock with hypercontractlity
-
2024-518293-13-01
9
Pulmonary embolism
-
2024-518821-13-00
4
Non-cystic Fibrosis Bronchiectasis
-
2024-519298-21-00
5
Cancer-Associated Thrombosis (CAT).
-
2024-519465-22-01
5
planned to be treated in the radiotherapy department of the participat
-
2024-519655-28-00
5
Premenopausal patients with high-risk HR-positive/HER2-negative breast
-
2024-519753-11-00
4
Resectable borderline pancreatic adenocarcinoma
-
2024-519818-31-01
5
Endometrial Cancer
Advanced, Recurrent, Metastatic, or Primary Unresec
-
2024-519894-20-01
5
Adult with an staphylococcal prosthetic joint infection treated with d
-
2024-520089-70-00
5
Cutaneous lupus erythematosus
-
2024-520391-10-01
5
Obstetrical Brachial Plexus Palsy
-
2024-520414-21-00
5
Adult patients with a LVOS with large core within 9 hours of symptoms
-
2025-520573-39-00
6
Ultra High Risk of psychosis and first episode psychosis
-
2025-520731-17-02
5
Pulmonary arterial hypertension (PAH)
-
2025-520976-25-00
4
Relapsed/refractory multiple myeloma
-
2025-521331-36-00
10
Patient with stabilized SSc-ILD (as defined by a decline of FVC ≤ 5%)
-
2025-521571-30-00
5
Young Adults and adults with R/R B-cell acute lymphoblastic leukemia (
-
2025-521619-37-00
5
Patients ≥75 years old with cT3/T4 rectal adenocarcinoma eligible to r
-
2025-522790-10-00
4
Non Small Cell Lung Cancer
-
2025-522791-92-00
5
Neoplasm Metastasis
-
2025-522855-25-00
5
Carcinoma, Transitional Cell
-
2025-523094-42-00
5
Hirschsprung's disease
-
2025-523157-34-00
5
Rett syndrome